These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16343057)

  • 1. Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
    Baranova A; Schlauch K; Gowder S; Collantes R; Chandhoke V; Younossi ZM
    Liver Int; 2005 Dec; 25(6):1091-6. PubMed ID: 16343057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease.
    Baranova A; Liotta L; Petricoin E; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):209-20, xi. PubMed ID: 17544980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [cDNA microarray technology as a laboratory examination method: a gene expression profiling test for analysis of drug resistance in tumor cells].
    Miyachi H; Kobayashi H; Asai S; Shinbata T; Arami S; Mitsuse S
    Rinsho Byori; 2002 Feb; 50(2):161-8. PubMed ID: 11925854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.
    Lemmer ER; Friedman SL; Llovet JM
    Semin Liver Dis; 2006 Nov; 26(4):373-84. PubMed ID: 17051451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling studies in ovarian cancer: a review.
    Fehrmann RS; Li XY; van der Zee AG; de Jong S; Te Meerman GJ; de Vries EG; Crijns AP
    Oncologist; 2007 Aug; 12(8):960-6. PubMed ID: 17766655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L; Commo F; Soria JC
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of microarray data: trudging out of the abyss towards elucidation of biological significance.
    Smith GW; Rosa GJ
    J Anim Sci; 2007 Mar; 85(13 Suppl):E20-3. PubMed ID: 17322122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A guide to issues in microarray analysis: application to endometrial biology.
    White CA; Salamonsen LA
    Reproduction; 2005 Jul; 130(1):1-13. PubMed ID: 15985627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
    Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
    BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profiling.
    Berzsenyi MD; Roberts SK; Beard MR
    Antivir Ther; 2006; 11(5):541-52. PubMed ID: 16964821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microarray: potential applications for ophthalmic research.
    Wilson AS; Hobbs BG; Speed TP; Rakoczy PE
    Mol Vis; 2002 Jul; 8():259-70. PubMed ID: 12131875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of microarray technology to neuropathology: cutting edge tool with clinical diagnostics potential or too much information?
    McShea A; Marlatt MW; Lee HG; Tarkowsky SM; Smit M; Smith MA
    J Neuropathol Exp Neurol; 2006 Nov; 65(11):1031-9. PubMed ID: 17086099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of glycosyltransferases and related enzymes using gene microarrays.
    Hammond JA; Head SR
    Methods Enzymol; 2006; 416():141-56. PubMed ID: 17113865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data merging for integrated microarray and proteomic analysis.
    Waters KM; Pounds JG; Thrall BD
    Brief Funct Genomic Proteomic; 2006 Dec; 5(4):261-72. PubMed ID: 16772273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology Insight: tuning into the genetic orchestra using microarrays--limitations of DNA microarrays in clinical practice.
    Abdullah-Sayani A; Bueno-de-Mesquita JM; van de Vijver MJ
    Nat Clin Pract Oncol; 2006 Sep; 3(9):501-16. PubMed ID: 16955089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Messenger RNA expression profiling using DNA microarray technology: diagnostic tool, scientific analysis or un-interpretable data?
    Walker MS; Hughes TA
    Int J Mol Med; 2008 Jan; 21(1):13-7. PubMed ID: 18097611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis.
    Sharma MR; Polavarapu R; Roseman D; Patel V; Eaton E; Kishor PB; Nanji AA
    Exp Mol Pathol; 2006 Dec; 81(3):202-10. PubMed ID: 16949573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From microarrays to mechanisms of brain development and function.
    Díaz E
    Biochem Biophys Res Commun; 2009 Jul; 385(2):129-31. PubMed ID: 19460360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M@IA: a modular open-source application for microarray workflow and integrative datamining.
    Le Béchec A; Zindy P; Sierocinski T; Petritis D; Bihouée A; Le Meur N; Léger J; Théret N
    In Silico Biol; 2008; 8(1):63-9. PubMed ID: 18430991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.